In a nutshell This trial aimed to evaluate the use of a second treatment targeting HER-2 in a group of patients that had HER-2, HR positive metastatic breast cancer. This study found that patients treated with dual HER-2 medications with hormone therapy had a superior progression free survival as compared to those using one medication...
Read MoreType(s) of biological therapy-Lapatinib (Tykerb) Posts on Medivizor
Retargeting: Treatment for metastatic HER2+ breast cancer that has progressed following targeted treatment
In a nutshell The authors reviewed the benefits and safety of ado–trastuzumab emtansine (Kadcyla), a treatment for metastatic breast cancer (cancer that has spread to other areas of the body). Some background Human epidermal growth factor receptor 2 positive (HER2) breast cancer depends on HER2 for growth. Treatments that target the HER2...
Read MoreWhat are the new strategies to overcome resistance to endocrine therapy in breast cancer?
In a nutshell This paper reviewed various strategies of preventing resistance to endocrine therapy. Some background Receptors are proteins found on cells that when activated can lead to cell growth and division. Estrogen receptors (protein found on cell) are one such example. Endocrine therapy is given to patients who have breast cancer with...
Read More